Financials data is unavailable for this security.
Inc stmt in GBPIncome statement in GBP
Year on year
Advanced Medical Solutions Group PLC grew revenues 20.45% from 68.60m to 82.62m while net income improved 11.14% from 14.12m to 15.69m.
|Net profit margin||18.99%|
|Return on assets||12.00%|
|Return on equity||13.69%|
|Return on investment||13.28%|
Cash flow in GBP
Advanced Medical Solutions Group PLC increased its cash reserves by 49.48%, or 16.92m. The company earned 19.83m from its operations for a Cash Flow Margin of 24.00%. In addition the company used 2.43m on investing activities and also paid 1.03m in financing cash flows.
|Cash flow per share||0.0875|
|Price/Cash flow per share||35.75|
|Book value per share||0.5964|
|Tangible book value per share||0.3401|
Balance sheet in GBP
|Total debt/total equity||0.00|
|Total debt/total capital||0.00|
Growth rates in GBP
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 15.00% and 10.44%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
|Div yield(5 year avg)||0.01%|
|Div growth rate (5 year)||15.38%|
|Payout ratio (TTM)||12.35%|
|EPS growth(5 years)||19.41|
|EPS (TTM) vs |
TTM 1 year ago